Literature DB >> 15746312

Efficient DNA fingerprinting of Clostridium botulinum types A, B, E, and F by amplified fragment length polymorphism analysis.

Riikka Keto-Timonen1, Mari Nevas, Hannu Korkeala.   

Abstract

Amplified fragment length polymorphism (AFLP) analysis was applied to characterize 33 group I and 37 group II Clostridium botulinum strains. Four restriction enzyme and 30 primer combinations were screened to tailor the AFLP technique for optimal characterization of C. botulinum. The enzyme combination HindIII and HpyCH4IV, with primers having one selective nucleotide apiece (Hind-C and Hpy-A), was selected. AFLP clearly differentiated between C. botulinum groups I and II; group-specific clusters showed <10% similarity between proteolytic and nonproteolytic C. botulinum strains. In addition, group-specific fragments were detected in both groups. All strains studied were typeable by AFLP, and a total of 42 AFLP types were identified. Extensive diversity was observed among strains of C. botulinum type E, whereas group I had lower genetic biodiversity. These results indicate that AFLP is a fast, highly discriminating, and reproducible DNA fingerprinting method with excellent typeability, which, in addition to its suitability for typing at strain level, can be used for C. botulinum group identification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746312      PMCID: PMC1065150          DOI: 10.1128/AEM.71.3.1148-1154.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  32 in total

1.  Biodiversity of Clostridium botulinum type E strains isolated from fish and fishery products.

Authors:  E Hyytiä; S Hielm; J Björkroth; H Korkeala
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

2.  Wound botulism associated with subcutaneous drug use.

Authors:  A F A Merrison; K E Chidley; J Dunnett; K A Sieradzan
Journal:  BMJ       Date:  2002-11-02

3.  Wound botulism in drug addicts in the United Kingdom.

Authors:  L Mulleague; S M Bonner; A Samuel; P Nichols; M Khan; S Shaw; T Grüning
Journal:  Anaesthesia       Date:  2001-02       Impact factor: 6.955

4.  Comparison of pulsed-field gel electrophoresis and amplified fragment length polymorphism techniques for investigating outbreaks of enteritis due to campylobacters.

Authors:  Olivia L Champion; Emma L Best; Jennifer A Frost
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material.

Authors:  M Lindström; R Keto; A Markkula; M Nevas; S Hielm; H Korkeala
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

6.  Characterisation of Clostridium botulinum groups I and II by randomly amplified polymorphic DNA analysis and repetitive element sequence-based PCR.

Authors:  E Hyytiä; J Björkroth; S Hielm; H Korkeala
Journal:  Int J Food Microbiol       Date:  1999-06-01       Impact factor: 5.277

7.  Differentiation of Campylobacter species by AFLP fingerprinting.

Authors:  Birgitta Duim; Peter A R Vandamme; Alan Rigter; Severine Laevens; Jeroen R Dijkstra; Jaap A Wagenaar
Journal:  Microbiology       Date:  2001-10       Impact factor: 2.777

8.  High-resolution genotyping of Campylobacter strains isolated from poultry and humans with amplified fragment length polymorphism fingerprinting.

Authors:  B Duim; T M Wassenaar; A Rigter; J Wagenaar
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

9.  Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism.

Authors:  Corné H W Klaassen; Hanneke A van Haren; Alfons M Horrevorts
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

10.  Amplified fragment length polymorphism (AFLP) analysis of Clostridium novyi, C. perfringens and Bacillus cereus isolated from injecting drug users during 2000.

Authors:  J McLAUCHLIN; J E Salmon; S Ahmed; J S Brazier; M M Brett; R C George; J Hood
Journal:  J Med Microbiol       Date:  2002-11       Impact factor: 2.472

View more
  21 in total

1.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis.

Authors:  Riikka Keto-Timonen; Annamari Heikinheimo; Erkki Eerola; Hannu Korkeala
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

4.  Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing.

Authors:  Thomas E Macdonald; Charles H Helma; Yulin Shou; Yolanda E Valdez; Lawrence O Ticknor; Brian T Foley; Stephen W Davis; George E Hannett; Cassandra D Kelly-Cirino; Jason R Barash; Stephen S Arnon; Miia Lindström; Hannu Korkeala; Leonard A Smith; Theresa J Smith; Karen K Hill
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

5.  Clostridium botulinum group I strain genotyping by 15-locus multilocus variable-number tandem-repeat analysis.

Authors:  Silvia Fillo; Francesco Giordani; Fabrizio Anniballi; Olivier Gorgé; Vincent Ramisse; Gilles Vergnaud; Julia M Riehm; Holger C Scholz; Wolf D Splettstoesser; Jasper Kieboom; Jaran-Strand Olsen; Lucia Fenicia; Florigio Lista
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

6.  Clostridium botulinum Group II Isolate Phylogenomic Profiling Using Whole-Genome Sequence Data.

Authors:  K A Weedmark; P Mabon; K L Hayden; D Lambert; G Van Domselaar; J W Austin; C R Corbett
Journal:  Appl Environ Microbiol       Date:  2015-06-26       Impact factor: 4.792

7.  Plasmid-borne type E neurotoxin gene clusters in Clostridium botulinum strains.

Authors:  Zhen Zhang; Hannamari Hintsa; Ying Chen; Hannu Korkeala; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2013-04-05       Impact factor: 4.792

8.  Comparative genomic hybridization analysis of two predominant Nordic group I (proteolytic) Clostridium botulinum type B clusters.

Authors:  Miia Lindström; Katja Hinderink; Panu Somervuo; Katri Kiviniemi; Mari Nevas; Ying Chen; Petri Auvinen; Andrew T Carter; David R Mason; Michael W Peck; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

9.  Genetic diversity among Clostridium botulinum strains harboring bont/A2 and bont/A3 genes.

Authors:  Carolina Lúquez; Brian H Raphael; Lavin A Joseph; Sarah R Meno; Rafael A Fernández; Susan E Maslanka
Journal:  Appl Environ Microbiol       Date:  2012-10-05       Impact factor: 4.792

10.  Quantitative real-time reverse transcription-PCR analysis reveals stable and prolonged neurotoxin cluster gene activity in a Clostridium botulinum type E strain at refrigeration temperature.

Authors:  Ying Chen; Hannu Korkeala; Jere Lindén; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2008-08-15       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.